Fecal transplant capsules for irritable bowel syndrome
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether taking capsules containing freeze-dried healthy donor stool can improve symptoms of irritable bowel syndrome (IBS) that haven't gotten better with usual treatments. It aims to see if this approach is safe and helpful for people with moderate to severe IBS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with irritable bowel syndrome (IBS) with moderate to severe symptoms (a score above 175 on a standard IBS questionnaire).
- Your IBS symptoms have not improved enough with standard treatments like antispasmodics, laxatives, or certain antidepressants.
- You are willing to swallow capsules containing freeze-dried stool from a healthy donor.
- You have not taken antibiotics in the last 3 months and do not have a serious immune system problem.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a freeze-dried fecal microbiota transplant (FMT) to see if it helps with diarrhea-predominant irritable bowel syndrome (IBS-D) or prevents repeat C. diff infections. FMT introduces healthy bacteria into your gut to restore balance.
This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
This trial tests whether transferring stool bacteria to the gut (fecal microbiota transplantation) can reduce symptoms of irritable bowel syndrome with constipation. It may help by changing the gut microbiome, but you must meet safety and health requirements.
Hear when a new Irritable Bowel Syndrome (IBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.